HOME >> MEDICINE >> NEWS
Women taking breast enhancement pills swallow empty promises

ARLINGTON HEIGHTS, Ill. Flip through any women's magazine and you are sure to find advertisements hawking pills to enlarge women's breasts. But do these pills actually work? Probably not, says the American Society of Plastic Surgeons (ASPS). Not only are breast enhancement pills unproven, they could be dangerous, according to a study published in Plastic and Reconstructive Surgery® (PRS), the official medical journal of the ASPS.

"There are upward of 30 different herbal products advertised widely on television, in magazines and on the Internet alleging to enhance the size of women's breasts; however, there have been no scientifically sound clinical trials proving they work," said Thomas Lawrence, MD, Chair of the Plastic Surgery Educational Foundation (PSEF) Device and Technique Assessment Committee.

Breast enhancement pills have become a lucrative industry in recent years due to their "guaranteed" safety and low cost compared to breast augmentation; however, these pills are sold as herbal supplements and are not subject to the U.S. Food and Drug Administration's scrutiny for safety and effectiveness. Although manufacturers claim to have studies that prove their products work, the majority of the data is derived from historical anecdotes and isolated, limited studies, according to PRS. While these pills promise an easy and inexpensive way to have larger breasts, many women may be placing their health in danger, the study states.

"It's what we don't know about these pills that scares many physicians," said Dr. Lawrence. "The primary active ingredients found in these supplements can be dangerous when mixed with other medications. Because many women who want bigger breasts self-prescribe these pills, they may be placing themselves in harms way without even knowing it."

According to the study, many breast enhancement pills contain one or more ingredients that can directly interfere with prescribed medications. For example, cha
'"/>

Contact: Brian Huggins
Bsh@plasticsurgery.org
847-228-9900
American Society of Plastic Surgeons
17-Nov-2004


Page: 1 2

Related medicine news :

1. The European Society of Cardiology launches Women at Heart
2. Women less likely to get quality heart attack care
3. Statement on the findings of the Womens Health Study
4. Women should be advised not to drink alcohol in pregnancy
5. Women with thyroid problem have lower risk of breast cancer
6. Women successfully treated to prevent preterm labor at low risk for recurrent episode
7. Womens heart risk underestimated by doctors, resulting in less preventive care than in men
8. Women, drinking to their health
9. Women want annual pap smears
10. Women In Government report on eliminating cervical cancer
11. Women need less morphine after hysterectomies with new treatment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Women taking breast enhancement pills swallow empty promises

(Date:1/22/2015)... 2015 AngelWeddingDress, the premier women’s dress ... wedding dresses. View website of AngelWeddingDress.com to ... maternity wedding dresses online for a bridal party. AngelWeddingDress ... quality for them. Its maternity wedding dresses are specially ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining ... policy . , Auto insurance quotes help many drivers ... longer necessary to call an agent or visit an agency ... a single website: http://autocarinsurancebest.com/ . , Every business who ...
(Date:1/22/2015)... 2015 Yesterday, Senator Holly Mitchell ... Kristin Olsen (R-Modesto) were honored by the California ... biotechnology, biomedical science, medical device and pharmaceutical innovation ... the “2014 Life Sciences Champion” award from CHI ...
(Date:1/22/2015)... January 22, 2015 EBSCO Information Services ... are expanding their relationship in an effort to further promote ... world. While EBSCO has long made AMA journals available via ... agent for The JAMA Network. , Long known ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Step into ... at the Science Museum of Virginia. Wicked Plants, the ... Wicked Plants unearths 75 poisonous, carnivorous and diabolical plants ... each room to uncover the biochemical, physical and neurological ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Wicked Plants are taking over the Science Museum of Virginia 2
(Date:1/23/2015)... , Jan. 23, 2015  HyGreen, Inc., a leader in ... partnership with RCA Medical, a subsidiary of Ascendis Health ... Each year, hundreds of millions of patients ... as organisms are transmitted from patient to patient via ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
Cached News: